United States · FDA National Drug Code directory
Hizentra
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 44206-457_411c01a7-0ae7-45d2-8b4c-cbe99a2ba264
- Product NDC
- 44206-457
- Form
- LIQUID
- Composition / generic term
- HUMAN IMMUNOGLOBULIN G
- Labeler
- CSL Behring AG
- Marketing category
- BLA
- Marketing start / end (source format)
- 20200101
- Source listing expiry
- 20261231
Source-listed ingredients
- HUMAN IMMUNOGLOBULIN G — .2 g/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE in 1 CARTON (44206-457-22) / 10 mL in 1 SYRINGE (44206-457-95) · 44206-457-22
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →